Farms.com Home   News

Produce industry members to voice concerns ahead of federal election

The Fruit and Vegetable Growers of Canada (FVGC) and the Canadian Produce Marketing Association (CPMA) will hold their fall joint advocacy event, Fall Harvest 2024, November 18-20, on Parliament Hill, in Ottawa.
 Fall Harvest is an annual event that provides produce industry members with unique opportunities to meet with Parliamentarians and other key government officials, to discuss critical issues impacting the Canadian fresh fruit and vegetable sector.
 The fresh fruit and vegetable industry is a vibrant part of the Canadian economy that works tirelessly to improve the health of Canadians while contributing $15 billion annually to Canada’s GDP, and supporting more than 185,000 jobs in communities across the country. As we look ahead to a potential federal election, now is the time to ensure that the voice of the Canadian produce sector is heard in Ottawa and work with the government to establish practical solutions that will advance the industry’s competitiveness in the global marketplace.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.